| PERIOD ENDING | 31-Jan-09 | 31-Jan-08 | 31-Jan-07 | | Total Revenue | 220,926 | 206,776 | 68,867 | | Cost of Revenue | 188,041 | 185,191 | 58,617 | | | Gross Profit | 32,885 | 21,585 | 10,250 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 14,858 | 18,983 | 9,863 | | Non Recurring | 3,134 | 6,826 |
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 14,893 | (4,224) | 387 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,755 | 3,311 | 349 | | Earnings Before Interest And Taxes | 17,155 | (913) | 736 | | Interest Expense | 410 | 699 | 760 | | Income Before Tax | 16,745 | (1,612) | (24) | | Income Tax Expense | 6,726 | 1,593 | 89 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 10,019 | (3,205) | (113) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 10,019 | (3,205) | (113) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $10,019 | ($3,205) | ($113) |
|
0.16% Nasdaq 
Income Statement
